Pregna International Ltd. of Mumbai at MEDICA 2019 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option
Manufacturers Trader Service OEM

Pregna International Ltd.

13 Suryoday Estate 136 Tardeo Road, 400034 Mumbai
India
Telephone +91 22 43454999
Fax +91 22 23513484
sales@pregna.com

Hall map

MEDICA 2019 hall map (Hall 6): stand E56

Fairground map

MEDICA 2019 fairground map: Hall 6

Contact

Abhishek Acharya

Phone
+912243454999

Email
abhishek.acharya@pregna.com

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.04  Therapy and physical medicine
  • 01.04.04  Cryotherapy, cryosurgery equipment

Cryotherapy, cryosurgery equipment

  • 05  Commodities and Consumer Goods
  • 05.01  Universal medical commodities

Our products

Product category: Universal medical commodities

Intrauterine contraceptive Device

Pregna Copper T 380A / Copper t Intrauterine device is a safe and trusted birth control device to ease unwanted pregnancy worries of the user for a period of up to 10 years

More Less

Product category: Universal medical commodities

Hormonal Intrauterine System - Eloira

Intrauterine System (IUS) / lng IUD consists of a Plastic frame with a reservoir containing drug Levonorgestrel. Levonorgestrel (LNG) hormone is also found in other oral contraceptives. This drug reservoir releases a low daily a microdose of (LNG) into the uterine cavity.

The Levonorgestrel IUD or lng IUD releases the hormone at an approximate rate of 20 micrograms per day and effective for five years.

IUS is a reversible contraceptive device & has high success rate and several non-contraceptive benefits too.

This intrauterine contraceptive device is embedded into the uterus by skilled provider. This contraceptive device is thought to be a standout amongst the best forms of birth control device available today.

More Less

Product category: Universal medical commodities

Intrauterine contraceptive Device - Etherena

Innovative device for loading of the T Cu 380 A  - with one hand and easy to use

More Less

Product category: Cryotherapy, cryosurgery equipment

CryoPop

CryoPop is a new device by Pregna International Ltd.  for treating cervical cancer.

More Less

Company news

Date

Topic

Download

Jun 19, 2018

5 Questions: Paul Blumenthal on contraception in India

Stanford researchers and their colleagues have tested a new contraceptive device that they say could provide broader access to long-acting contraception in developing countries.
In the past 10 years, the percentage of women who use intrauterine devices in the United States has leapt from less than 1 percent to nearly 20 percent. But at the international level, those figures are much lower.

Paul Blumenthal, MD, MPH, professor of obstetrics and gynecology at the School of Medicine, focuses much of his work on family planning in developing countries, many of which do not have broad access to long-acting contraception. Blumenthal’s latest paper, published in collaboration with Population Services International, describes the implementation of a new device used to insert IUDs in women immediately after they give birth, and he hopes it will help health care professionals in developing countries provide broader access to long-acting contraceptives.

The idea behind Blumenthal’s postpartum IUD inserter, which comes with the IUD packaged inside it, is to simplify and streamline the process of providing women with birth control. In a clinical trial with 500 participants, health care providers in India used either Blumenthal’s IUD inserter or the traditional forceps method to place the contraceptive, comparing their efficacy, ease and safety.

A paper detailing the clinical trial was published online May 8 in Contraception. Blumenthal is the senior author.

Blumenthal’s goal is to bring simple, affordable contraception to the masses — particularly in developing countries. Establishing the inserter’s legitimacy in this trial, Blumenthal said, is a step in that direction. Recently, he spoke with science writer Hanae Armitage about the details of this work, the drivers behind it and how he hopes to see it pan out on an international scale.


Q: With the Drug Controller General of India's approval for commercial use, how will you scale up the process in India, and do you plan to bring this option to women in other developing countries as well?

Blumenthal: We’re working with a third-party company called Pregna International. They’re based in India, and they manufacture IUDs used in programs worldwide. Now with commercial approval, Pregna can market this inserter to the public and private sector in India and reach potentially millions of women. At the same time, other nongovernmental organizations that are working in the family planning area can also recommend this to their programs in India, and that will likely enhance the public-sector programs as well. Currently, the IUD inserter is under review by the United Nations Family Planning Assistance Program, and we hope that this publication will serve to help the UNFPA in its deliberation. Hopefully, that will allow for prequalification of the device, so that it can be used in UNFPA publicly-funded programs that reach other developing countries in sub-Saharan Africa and South Asia.

By
HANAE ARMITAGE
Hanae Armitage is a science writer for the medical school's Office of Communication & Public Affairs.

More Less

Mar 23, 2016

Study finds benefits of device for inserting IUDs shortly after birth

A Stanford researcher helped devise a simple IUD inserter for use in developing countries to help women seeking contraceptive options after delivery.

A simple tool designed for inserting an intrauterine device may offer women in the developing world a convenient, low-cost option for long-term contraception.

Practitioners can easily and effectively use the device in low-resource settings to place an IUD in women just after they’ve given birth, according to a pilot study led by a Stanford University School of Medicine researcher.

Paul Blumenthal, MD, professor of obstetrics and gynecology, collaborated with colleagues at Population Services International to invent the device, the first of its kind. It consists of a long tube of silicone and plastic, preloaded with an IUD, that can be inserted into the top portion of the uterus, where it may provide contraceptive protection for as long as 10 years. 

“It’s simple, it works and it’s cheap,” Blumenthal said. “This is something that could really enhance the providers’ willingness and the patients’ acceptability of this approach.”

He and his colleagues at PSI-India tested the inserter device in 80 women in India, who said placement of the IUD caused them little or no additional pain compared with the birth of their child.

He said an Indian company, Pregna International, which refined and manufactured the device for the pilot study, is keen to bring it to market.

The work was funded by an innovation grant called The Saving Lives at Birth: A Grand Challenge for Development, in partnership with the U.S. Agency for International Development, the government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada (funded by the government of Canada) and the UK’s Department for International Development. 

Stanford’s Department of Obstetrics and Gynecology and PSI also supported the work.

By
RUTHANN RICHTER
Ruthann Richter is the director of media relations for the medical school's Office of Communication & Public Affairs.

More Less

About us

Company details

Pregna is a leading Contraceptive Solutions Organization and has been serving women since 1991. Pregna is spread across the globe in 145 countries partnering with social marketing organizations as well as private distributors in the area of Intra- uterine devices.

Pregna is the largest IUD manufacturer in the world and so far 100 million women have been served. Pregna is ISO 9001: 2008, CE, WHO GMP, ISO 14001, ISO 13485 certified and has an in-house Research and Development Team which has contributed towards many breakthrough products including value add-on to existing models.

More Less

Company data

Export content

> 75%

Area of business
  • Electromedical equipment / Medical Technology
  • Commodities and Consumer Good for Surgeries and Hospitals